Healthcare - Sector
Adverum Biotechnologies's activity chart (see below) currently has 66 price targets and 70 ratings on display.
Analysts' price targets on this stock were met 43.13% of the time, taking 324.72 days on average.
Most recent stock forecast was given by from HC WAINWRIGHT on 17-Nov-2025.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Apr-2024
$5
1 years 4 days ago
(17-Nov-2025)
0/5 (0%)
$0.73 (17.10%)
Buy Since 01-Nov-2023
$5.5
$12
1 years 23 days ago
(29-Oct-2025)
1/7 (14.29%)
$1.27 (30.02%)
292
Hold Since 16-Apr-2025
$4
$5
1 years 24 days ago
(28-Oct-2025)
1/2 (50%)
$-0.26 (-6.10%)
168
Buy Since 18-Jul-2024
1 years 3 months 8 days ago
(13-Aug-2025)
2/3 (66.67%)
$30.52 (321.94%)
1046
Hold Since 19-Mar-2024
$4
$5
1 years 6 months 6 days ago
(15-May-2025)
4/6 (66.67%)
$1.95 (95.12%)
205
What is ADVM (Adverum Biotechnologies) average time for price targets to be met?
Which analyst most recently updated their price target on ADVM (Adverum Biotechnologies)?
Which analyst has the most public recommendations on ADVM (Adverum Biotechnologies)?
Which analyst is the currently most bullish on ADVM (Adverum Biotechnologies)?
Which analyst is the currently most reserved on ADVM (Adverum Biotechnologies)?